Geron Corp (GERN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Geron reported revenue of $183.6M, up 140.0% from $76.5M the year before. Net income was -$83.5M (a -45.5% net margin), or -$0.13 per diluted share. Operating margin was -37.4%. Operating activities generated -$111.0M of cash. At fiscal year end, Geron held $570.5M in total assets against $344.7M in total liabilities, including $77.6M of cash and equivalents.
Open the full interactive Geron financials → Quarterly statements, key ratios, valuation history and price charts.
Geron Key Stats
| Share Price | $1.20 |
|---|---|
| Market Cap | $804.8M |
| Revenue YoY Growth | +140.1% |
| 52-Week Range | $1.07 – $1.95 |
| Shares Outstanding | 670.7 million (basic, 2026 Q2) |
Geron Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $253,000 | $1.4M | $596,000 | $237,000 | $76.5M | $183.6M |
| Operating Income | -$76.9M | -$114.0M | -$138.6M | -$193.9M | -$173.7M | -$68.6M |
| Pre-Tax Income | -$75.6M | -$116.1M | -$141.9M | -$184.1M | -$174.5M | -$83.4M |
| Income Tax | — | — | — | — | $449,000 | $75,000 |
| Net Income | -$75.6M | -$116.1M | -$141.9M | -$184.1M | -$174.6M | -$83.5M |
| Diluted EPS | -$0.28 | -$0.35 | -$0.37 | -$0.32 | -$0.27 | -$0.13 |
Geron Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $47.2M | $47.8M | $51.8M | $57.5M |
| Net Income | -$18.4M | -$28.9M | -$3.6M | -$16.7M |
| Diluted EPS | -$0.03 | -$0.04 | -$0.01 | -$0.02 |
Geron Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.9M | $34.9M | $56.8M | $70.0M | $79.0M | $77.6M |
| Current Assets | $199.9M | $187.2M | $180.2M | $341.3M | $491.0M | $520.3M |
| Total Assets | $270.7M | $226.0M | $190.6M | $394.1M | $593.8M | $570.5M |
| Current Liabilities | $30.9M | $45.5M | $76.7M | $108.1M | $88.3M | $111.5M |
| Total Long-Term Debt | $24.0M | $49.8M | $51.2M | $81.9M | $118.5M | $119.5M |
| Total Liabilities | $59.8M | $99.6M | $110.6M | $146.1M | $313.5M | $344.7M |
| Shareholders' Equity | $210.9M | $126.4M | $80.0M | $247.9M | $280.3M | $225.9M |
Geron Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$66.7M | -$95.6M | -$127.4M | -$167.7M | -$218.6M | -$111.0M |
| Cash From Investing | -$105.3M | $71.9M | $62.1M | -$180.3M | -$106.0M | $107.2M |
| Cash From Financing | $168.3M | $48.6M | $87.3M | $362.0M | $334.4M | $2.3M |
| Free Cash Flow | -$67.1M | -$95.8M | -$127.8M | -$168.6M | -$219.3M | — |
Figures from Geron's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Geron financials page for every line item.
Geron Company Profile
| Ticker | GERN |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Foster City, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000886744 |
Frequently Asked Questions
What was Geron's revenue in fiscal 2025?
Geron (GERN) reported revenue of $183.6M for fiscal 2025.
What is Geron's annual revenue history?
Geron's annual revenue by fiscal year: 2020: $253,000; 2021: $1.4M; 2022: $596,000; 2023: $237,000; 2024: $76.5M; 2025: $183.6M.
What was Geron's net income in fiscal 2025?
Geron reported net income of -$83.5M for fiscal 2025.
What was Geron's earnings per share (EPS) in fiscal 2025?
Geron's diluted EPS was -$0.13 for fiscal 2025 (adjusted for any later stock splits).
What was Geron's revenue last quarter?
In its most recent reported quarter (2026 Q2), Geron reported revenue of $57.5M.
How much debt does Geron have?
Geron reported $119.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Geron are outstanding?
Geron reported a weighted average of 670.7 million basic shares outstanding in 2026 Q2.
What is Geron's market cap?
Based on its latest closing price, Geron (GERN) has a market capitalization of about $804.8M.
When does Geron's fiscal year end?
Geron's fiscal year end, as registered with the SEC, is December 31.
Where is Geron headquartered?
Geron lists its business address in Foster City, California in its SEC filings.